Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
Status:
Recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial will evaluate the initial safety and feasibility of microbiota
transplant therapy (MTT) inpatients with primary sclerosing cholangitis (PSC). This trial
will inform development of future trials in treatment of PSC.